Yuya Hirai, Takahiro Mimae, Morihito Okada. ASO Author Reflections: Can Pathological Invasion Status Help Select Patients for Adjuvant Chemotherapy in Stage II–III Non-small Cell Lung Cancer?. // Annals of Surgical Oncology. – 2026. – DOI: 10.1245/s10434-026-20920-w. – URL: https://doi.org/10.1245/s10434-026-20920-w
Yuya Hirai, Takahiro Mimae, & Morihito Okada (2026). ASO Author Reflections: Can Pathological Invasion Status Help Select Patients for Adjuvant Chemotherapy in Stage II–III Non-small Cell Lung Cancer?. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-026-20920-w
Yuya Hirai, et al. “ASO Author Reflections: Can Pathological Invasion Status Help Select Patients for Adjuvant Chemotherapy in Stage II–III Non-small Cell Lung Cancer?.” Annals of Surgical Oncology, 2026. doi:10.1245/s10434-026-20920-w.
@article{Hirai2026,
title = {ASO Author Reflections: Can Pathological Invasion Status Help Select Patients for Adjuvant Chemotherapy in Stage II–III Non-small Cell Lung Cancer?},
author = {Hirai, Yuya and Mimae, Takahiro and Okada, Morihito},
journal = {Annals of Surgical Oncology},
year = {2026},
doi = {10.1245/s10434-026-20920-w},
url = {https://doi.org/10.1245/s10434-026-20920-w}
}